Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Sell
29
AKBA Quote, Financials, Valuation and Earnings
Last price:
$1.65
Seasonality move
:
9.5%
Day range:
$1.52 - $1.71
52-week range:
$0.80 - $2.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.04x
P/B ratio:
--
Volume:
7.3M
Avg. volume:
5.5M
1-year change:
-0.64%
Market cap:
$404.9M
Revenue:
$160.2M
EPS (TTM):
-$0.33
AKBA Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for Akebia Therapeutics shares anticipate an average target of $7.38, ranging from a low estimate of $6.00 to a high estimate of $10.00. This average target implies a growth of 375.81% compared to the current stock price of $1.55.
Consensus Price Target
$7.38
Highest Price Target
$10.00
Lowest Price Target
$6.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
AKBA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Is Archer Aviation a Buy, Sell or Hold?
Vertical takeoff and landing (eVTOL) aircraft sound futuristic but that’s…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 31x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Sell
11
CRL alert for Apr 11
Charles River Laboratories International [CRL] is down 0.2% over the past day.
Buy
77
DPST alert for Apr 11
Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 0.79% over the past day.
Sell
35
KMX alert for Apr 11
CarMax [KMX] is up 2.87% over the past day.
